Fisher & Paykel Healthcare Corporation Limited (NZE:FPH)
47.00
+0.50 (1.08%)
Oct 7, 2026, 5:00 PM NZST
NZE:FPH Stock Forecast
Stock Price Forecast
According to 12 analysts polled by S&P Global, NZE:FPH stock has a consensus rating of "Buy" and an average price target of $45.19. The average 1-year stock price forecast is 3.85% lower than the current stock price, while the lowest is $30.50 (-35.11%) and the highest is $52.00 (+10.64%).
Price Target: $45.19 (-3.85%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for NZE:FPH stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 4 | 4 |
| Buy | 2 | 2 | 2 | 2 | 3 | 3 |
| Hold | 6 | 6 | 6 | 6 | 4 | 4 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 12 | 12 | 12 | 12 | 12 | 12 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Buy Upgrades $39.00 → $52.00 | Buy | Upgrades | $39.00 → $52.00 | +10.64% | Sep 15, 2026 |
| Citi | Citi | Buy Upgrades $40.00 → $51.00 | Buy | Upgrades | $40.00 → $51.00 | +8.51% | Sep 10, 2026 |
| Jefferies | Jefferies | Buy Maintains $52.43 | Buy | Maintains | $52.43 | +11.56% | Sep 1, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Maintains $53.54 | Buy | Maintains | $53.54 | +13.92% | Aug 25, 2026 |
| Jarden | Jarden | Hold Maintains n/a | Hold | Maintains | n/a | n/a | Aug 24, 2026 |
Financial Forecast
Revenue This Year
2.56B
from 2.31B
Increased by 10.94%
Revenue Next Year
2.86B
from 2.56B
Increased by 11.82%
EPS This Year
0.94
from 0.79
Increased by 18.73%
EPS Next Year
1.09
from 0.94
Increased by 16.21%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is NZD.